Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingshu Sun

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Arthritis Research & Therapy|March 10, 2022
A machine learning-assisted model for renal urate underexcretion with genetic and clinical variables among Chinese men with goutMingshu Sun, Wenyan Sun, Xuetong Zhao, et al.
Arthritis Research & Therapy|September 4, 2019
Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective, randomized controlled study in a Chinese primary gout cohortNan Liang, Mingshu Sun, Ruixia Sun, et al.
Rheumatology (Oxford, England)|February 11, 2025
Impact of adding urine alkalization therapy to xanthine oxidase inhibitor in gout management: a prospective cohort studyCan Wang, Kai Guo, Nicola Dalbeth, et al.
Rheumatology (Oxford, England)|November 6, 2024
An artificial intelligence-based gout management system reduced chronic kidney disease incident and improved target serum urate achievementHan Qi, Jie Lu, Nicola Dalbeth, et al.
Rheumatology (Oxford, England)|November 21, 2022
Elevated serum CA72-4 predicts gout flares during urate lowering therapy initiation: a prospective cohort studyShuhui Hu, Mingshu Sun, Maichao Li, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 7, 2022
Superiority of Low-Dose Benzbromarone to Low-Dose Febuxostat in a Prospective, Randomized Comparative Effectiveness Trial in Gout Patients With Renal Uric Acid UnderexcretionFei Yan, Xiaomei Xue, Jie Lu, et al.
International Journal of Rheumatic Diseases|July 22, 2025
Clinical Practice Consensus Statement 2025: Management of Hyperuricemia and Gout in AdolescentsChanggui Li, Jie Lu, Zhaohui Lyu, et al.
Arthritis Care & Research|August 30, 2025
Perceptions about asymptomatic hyperuricemia and views about urate-lowering therapy in people with asymptomatic hyperuricemiaNicola Dalbeth, Sarah Stewart, Gregory D Gamble, et al.
BMJ Open|November 7, 2024
Development of gout in people with asymptomatic hyperuricemia: study protocol for a 5-year prospective cohortSarah Stewart, Greg Gamble, William Taylor, et al.
International Journal of Rheumatic Diseases|July 22, 2025
2024 Update of Chinese Guidelines for Diagnosis and Treatment of Hyperuricemia and Gout Part I: Recommendations for General PatientsMingshu Sun, Zhaohui Lyu, Can Wang, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Arthritis Research & Therapy|March 10, 2022
A machine learning-assisted model for renal urate underexcretion with genetic and clinical variables among Chinese men with goutMingshu Sun, Wenyan Sun, Xuetong Zhao, et al.
Arthritis Research & Therapy|September 4, 2019
Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective, randomized controlled study in a Chinese primary gout cohortNan Liang, Mingshu Sun, Ruixia Sun, et al.
Rheumatology (Oxford, England)|February 11, 2025
Impact of adding urine alkalization therapy to xanthine oxidase inhibitor in gout management: a prospective cohort studyCan Wang, Kai Guo, Nicola Dalbeth, et al.
Rheumatology (Oxford, England)|November 6, 2024
An artificial intelligence-based gout management system reduced chronic kidney disease incident and improved target serum urate achievementHan Qi, Jie Lu, Nicola Dalbeth, et al.
Rheumatology (Oxford, England)|November 21, 2022
Elevated serum CA72-4 predicts gout flares during urate lowering therapy initiation: a prospective cohort studyShuhui Hu, Mingshu Sun, Maichao Li, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 7, 2022
Superiority of Low-Dose Benzbromarone to Low-Dose Febuxostat in a Prospective, Randomized Comparative Effectiveness Trial in Gout Patients With Renal Uric Acid UnderexcretionFei Yan, Xiaomei Xue, Jie Lu, et al.
International Journal of Rheumatic Diseases|July 22, 2025
Clinical Practice Consensus Statement 2025: Management of Hyperuricemia and Gout in AdolescentsChanggui Li, Jie Lu, Zhaohui Lyu, et al.
Arthritis Care & Research|August 30, 2025
Perceptions about asymptomatic hyperuricemia and views about urate-lowering therapy in people with asymptomatic hyperuricemiaNicola Dalbeth, Sarah Stewart, Gregory D Gamble, et al.
BMJ Open|November 7, 2024
Development of gout in people with asymptomatic hyperuricemia: study protocol for a 5-year prospective cohortSarah Stewart, Greg Gamble, William Taylor, et al.
International Journal of Rheumatic Diseases|July 22, 2025
2024 Update of Chinese Guidelines for Diagnosis and Treatment of Hyperuricemia and Gout Part I: Recommendations for General PatientsMingshu Sun, Zhaohui Lyu, Can Wang, et al.
Pageof 4